Home Medical stocks Varian Medical Systems, Inc. And 5 Other Stocks Have High Sales Growth...

Varian Medical Systems, Inc. And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

70
0

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. First Horizon National Corporation

61.5% sales growth and 11.16% return on equity

First Horizon National Corporation operates as the bank holding company for First Horizon Bank that provides various financial services.

First Horizon National Corporation’s sales growth this year is anticipated to be 51.8% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 62.2%, now sitting on 1.94B for the twelve trailing months.

First Horizon National Corporation’s sales growth for the next quarter is 61.5%. The company’s growth estimates for the ongoing quarter and the next is a negative 29.8% and 540%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.16%.

Volatility

First Horizon National Corporation’s last day, last week, and last month’s average volatility was 4.25%, 3.24%, and 0.64%, respectively.

First Horizon National Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 4.35%, 4.05%, and 2.75%, respectively.

First Horizon National Corporation’s Stock Yearly Top and Bottom Value

First Horizon National Corporation’s stock is valued at $14.65 at 01:22 EST, way under its 52-week high of $17.40 and way higher than its 52-week low of $6.27.

First Horizon National Corporation’s Moving Average

First Horizon National Corporation’s value is way higher than its 50-day moving average of $12.84 and way higher than its 200-day moving average of $10.62.

2. Bridgeline Digital, Inc.

9.6% sales growth and 4.62% return on equity

Bridgeline Digital, Inc. operates as a digital engagement company in the United States.

Bridgeline Digital, Inc.’s sales growth this year is anticipated to be 14.1% and a negative 0% for next year.

Year-on-year quarterly revenue growth grew by 0.6%, now sitting on 10.91M for the twelve trailing months.

Bridgeline Digital, Inc.’s sales growth for the next quarter is 9.6%. The company’s growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.62%.

Volatility

Bridgeline Digital, Inc.’s last day, last week, and last month’s average volatility was a negative 1.78%, a positive 1.77%, and a negative 0.06%, respectively.

Bridgeline Digital, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 6.91%, 6.24%, and 8.12%, respectively.

Bridgeline Digital, Inc.’s Stock Yearly Top and Bottom Value

Bridgeline Digital, Inc.’s stock is valued at $2.81 at 01:22 EST, way below its 52-week high of $3.62 and way higher than its 52-week low of $0.53.

Bridgeline Digital, Inc.’s Moving Average

Bridgeline Digital, Inc.’s worth is above its 50-day moving average of $2.71 and way higher than its 200-day moving average of $2.25.

3. Amedisys Inc

13.8% sales growth and 24.62% return on equity

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States.

Amedisys Inc’s sales growth this year is anticipated to be 5.8% and 11.1% for next year.

Year-on-year quarterly revenue growth grew by 10%, now sitting on 2.02B for the twelve trailing months.

Amedisys Inc’s sales growth for the next quarter is 13.8%. The company’s growth estimates for the present quarter and the next is 55.3% and 39%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.62%.

Volatility

Amedisys Inc’s last day, last week, and last month’s average volatility was 1.20%, 0.93%, and 0.78%, respectively.

Amedisys Inc’s last day, last week, and last month’s high and low average amplitude percentage was 2.03%, 3.28%, and 3.09%, respectively.

Amedisys Inc’s Stock Yearly Top and Bottom Value

Amedisys Inc’s stock is valued at $307.07 at 01:22 EST, under its 52-week high of $309.38 and way above its 52-week low of $132.95.

Amedisys Inc’s Moving Average

Amedisys Inc’s worth is way above its 50-day moving average of $271.89 and way higher than its 200-day moving average of $242.31.

4. Varian Medical Systems, Inc.

10.3% sales growth and 13.95% return on equity

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide.

Varian Medical Systems, Inc.’s sales growth this year is anticipated to be 12.9% and 9.9% for next year.

Year-on-year quarterly revenue growth declined by 3.2%, now sitting on 3.17B for the twelve trailing months.

Varian Medical Systems, Inc.’s sales growth for the next quarter is 10.3%. The company’s growth estimates for the present quarter and the next is a negative 5.2% and 40%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.95%.

Volatility

Varian Medical Systems, Inc.’s last day, last week, and last month’s average volatility was a negative 0.05%, a positive 0.08%, and a positive 0.03%, respectively.

Varian Medical Systems, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 0.23%, 0.30%, and 0.27%, respectively.

Varian Medical Systems, Inc.’s Stock Yearly Top and Bottom Value

Varian Medical Systems, Inc.’s stock is valued at $175.70 at 01:22 EST, under its 52-week high of $176.19 and way higher than its 52-week low of $89.62.

Varian Medical Systems, Inc.’s Moving Average

Varian Medical Systems, Inc.’s worth is higher than its 50-day moving average of $174.62 and higher than its 200-day moving average of $163.66.

5. ACM Research, Inc.

80.6% sales growth and 10.8% return on equity

ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide.

ACM Research, Inc.’s sales growth this year is anticipated to be 42.1% and 41.9% for next year.

Year-on-year quarterly revenue growth grew by 42.6%, now sitting on 135.67M for the twelve trailing months.

ACM Research, Inc.’s sales growth for the next quarter is 80.6%. The company’s growth estimates for the current quarter and the next is 17.4% and 163.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.8%.

Volatility

ACM Research, Inc.’s last day, last week, and last month’s average volatility was a negative 2.84%, a positive 2.23%, and a positive 1.62%, respectively.

ACM Research, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 4.02%, 6.13%, and 6.90%, respectively.

ACM Research, Inc.’s Stock Yearly Top and Bottom Value

ACM Research, Inc.’s stock is valued at $99.99 at 01:22 EST, way below its 52-week high of $113.87 and way above its 52-week low of $15.95.

ACM Research, Inc.’s Moving Average

ACM Research, Inc.’s worth is way higher than its 50-day moving average of $80.14 and way above its 200-day moving average of $81.27.

6. Sony

21.2% sales growth and 19.92% return on equity

Sony Corporation designs, develops, produces, and sells electronic equipment, instruments, and devices for the consumer, professional, and industrial markets worldwide.

Sony’s sales growth this year is anticipated to be 12.1% and 4% for next year.

Year-on-year quarterly revenue growth declined by 0.4%, now sitting on N/A for the twelve trailing months.

Sony’s sales growth for the next quarter is 21.2%. The company’s growth estimates for the present quarter and the next is a negative 52.4% and 190%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.92%.

Volatility

Sony’s last day, last week, and last month’s average volatility was a negative 0.45%, a positive 0.28%, and a positive 0.49%, respectively.

Sony’s last day, last week, and last month’s high and low average amplitude percentage was 0.72%, 1.13%, and 1.23%, respectively.

Sony’s Stock Yearly Top and Bottom Value

Sony’s stock is valued at $102.05 at 01:22 EST, under its 52-week high of $105.00 and way above its 52-week low of $50.94.

Sony’s Moving Average

Sony’s worth is above its 50-day moving average of $97.81 and way above its 200-day moving average of $83.49.

Previous days news about Sony

According to Business Insider on Friday, 15 January, “Mitsubishi Electric, Sony and Panasonic are declining more than 1 percent each, while Canon is gaining more than 7 percent.”

According to Business Insider on Friday, 15 January, “Mitsubishi Electric, Sony and Panasonic are declining more than 1 percent each, while Canon is gaining more than 7 percent.”

According to Business Insider on Friday, 15 January, “Since its founding 20 years ago, 180’s approach to creative has gotten the world talking and iconic brands like adidas, Sony PlayStation and HP growing. “

According to Bloomberg Quint on Saturday, 16 January, “It performed so poorly that Sony Corp. removed the game from the PlayStation Store and offered refunds, an unprecedented move, while Microsoft Corp. slapped on a label warning customers that they “may experience performance issues on Xbox One until the game is updated.” CD Projekt is facing an investor lawsuit on claims they were misled.”

According to The Wall Street Journal on Monday, 18 January, “Morbius,” a “Spider-Man” spinoff scheduled for release by Sony Pictures Entertainment on March 19, will now debut on Oct. 8, giving the studio a seven-month leeway and delaying what was expected to be the first big-budget, wide-release offering since theaters closed last March.”

https://via.news/markets/varian-medical-systems-inc-and-5-other-stocks-have-high-sales-growth-and-an-above-3-return-on-equity-2/
https://via.news/markets/varian-medical-systems-inc-and-5-other-stocks-have-high-sales-growth-and-an-above-3-return-on-equity-2/

This site uses Akismet to reduce spam. Learn how your comment data is processed.